# Simcere

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/simcere

- Industry: Healthcare
- Headquarters: Nanjing, China
- Total disclosed funding: $94M
- Latest round: Series B (Jun 3, 2021)
- Investors on record: 13

## About

Based in Nanjing, China and founded in 2017, Jiangsu Simcere Medical Diagnostics Co., Ltd., trading as Simcere, is a precision medical solution provider under Sincere Pharmaceutical Group Limited, providing medical diagnostic products and services.

The company's main product is a SDx MassARRAY MALDI-TOF mass spectrometric detection system based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), which can be applied to tumor detection, pharmacogenomics detection, infectious disease detection and genetic disease detection, etc. Besides, the company also operates as a personal testing platform, YOAI MEDICINE, providing services such as cervical cancer screening, vaginitis testing, and venereal disease testing.

The company generates revenue by providing precision medicine solutions for healthcare professionals in the fields of oncology, central nervous system, infectious diseases, pharmacogenomic, and autoimmune diseases.

## Funding rounds

- Series B, Jun 3, 2021, $94M — GP Capital, CITIC Securities, Shanghai Creation Investment, Jadestone Capital, Jolmo Capital, Yingke Private Equity, HosenCare Brothers, CITIC Med Fund, Nanjing Innovation Capital Group, Guangzhou Tianhui Capital Management
- Series A, Oct 13, 2020 — Hony Capital, Huatai Zijin Investment, Tenyall

## Investors

- Hony Capital (https://capitalatlas.ai/funds/hony-capital) — Series A
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series A
- Tenyall — Series A
- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series B
- CITIC Securities — Series B
- Shanghai Creation Investment (https://capitalatlas.ai/funds/shanghai-creation-investment) — Series B
- Jadestone Capital (https://capitalatlas.ai/funds/jadestone-capital) — Series B
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series B
- Yingke Private Equity (https://capitalatlas.ai/funds/yingke-private-equity) — Series B
- HosenCare Brothers (https://capitalatlas.ai/funds/hosencare-brothers) — Series B
- CITIC Med Fund (https://capitalatlas.ai/funds/citic-med-fund) — Series B
- Nanjing Innovation Capital Group — Series B
- Guangzhou Tianhui Capital Management — Series B